logo
Plus   Neg
Share
Email

Teva: AUSTEDO Approved In China In Treatment Of Chorea - Quick Facts

Teva Pharmaceutical Industries Ltd. (TEVA) announced the China National Medical Products Administration has approved AUSTEDO for the treatment of chorea associated with Huntington's disease and Tardive Dyskinesia in adults. The company will commercialize AUSTEDO in China independently.

Teva Pharma noted that this is the second approval and expected launch in China of a Teva specialty medicine, following the recent launch of TREANDA.

Gianfranco Nazzi, Executive Vice President, International Markets, at Teva, stated: "We look forward to bringing more of the essential medicines in our portfolio to patients in China, and to fuel organic growth and expand our presence in this important market."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter could face a fine of up to $250 million from the U.S. Federal Trade Commission regarding its use of phone numbers and email addresses to target advertisements. Lord & Taylor joined the growing list of U.S. retailers who filed for bankruptcy amid the coronavirus pandemic. Lord & Taylor, one of the oldest department store chains in the U.S., filed for bankruptcy protection in the Eastern Court of Virginia on Sunday. The company operated 38 stores that have remained temporarily closed since March this year due to the pandemic. Thomson International Inc. is recalling Red, Yellow, White, and Sweet Yellow Onions for potential contamination with Salmonella, according to a statement by the U.S. Food and Drug Administration or FDA. The onions are in distribution since May 1, 2020. They were sold to wholesalers, restaurants, and retail stores in all 50 U.S. states, the District of Columbia and Canada.
Follow RTT